QQ客服 官方微博 反馈留言

	Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells
	Zhang, Wen; Bao, Li; Yang, Shaoxing; Qian, Zhaoyang; Dong, Mei; Yin, Liyuan; Zhao, Qian; Ge, Keli; Deng, Zhenling; Zhang, Jing
	2016
卷号	7期号:26页码:39768-39783
关键词	viable circulating tumor cells epithelial-marker-independent telomerase-specific HSV clinical application
ISSN号	1949-2553
DOI	10.18632/oncotarget.9465
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6383539
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhang, Wen,Bao, Li,Yang, Shaoxing,et al. Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells[J],2016,7(26):39768-39783.
APA	Zhang, Wen.,Bao, Li.,Yang, Shaoxing.,Qian, Zhaoyang.,Dong, Mei.,...&Cheng, Shujun.(2016).Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells.,7(26),39768-39783.
MLA	Zhang, Wen,et al."Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells".7.26(2016):39768-39783.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。